NR3C2 and atherosclerosis: Other MR blockers, such as spironolactone32 and eplerenone33,34 showed anti-atherosclerotic effects, but both drugs decreased blood pressure and improved lipid profile both of which are well known to reduce the progression of atherosclerosis.